Results 11 to 20 of about 5,138 (149)

Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using BIFAP database in Spain

Pharmacoepidemiology and Drug Safety, Volume 32, Issue 4, Page 397-406, April 2023., 2023
Abstract Background Tramadol, a weak opioid, inhibits the reuptake of serotonin, a key feature on vascular homeostasis. A suspected interaction exists between dabigatran and tramadol, which might trigger an excess on risk of bleeding however, there is a gap in knowledge on this topic.
Airam de Burgos‐Gonzalez, Consuelo Huerta, María José Peñalver, Luis Sordo, José Pulido, Lucía Cea Soriano   +5 more
wiley   +1 more source

Nurses competence in the reporting of medication‐related incidents: An intervention study

Nursing Open, Volume 9, Issue 6, Page 2836-2846, November 2022., 2022
Abstract Objectives Less than 5% of all harmful medicine‐related incidents (MIs) or adverse drug reactions received by the Spanish Pharmacovigilance system are notified by Registered Nurses (RNs). The main objective of this study was to determine the impact of a multifaceted institutional intervention (MII) in patient safety on the reporting competence
Isabel Salcedo‐Diego, Belén Ruiz‐Antorán, Concepción Payares‐Herrera, Begoña de Andrés‐Gimeno, Pilar Serrano‐Gallardo   +4 more
wiley   +1 more source

Autoimmune Idiopathic Inflammatory Myopathies: Pharmacological Differences and Similarities by Type of Myositis and by Sociodemographic Variables

International Journal of Rheumatology, Volume 2022, Issue 1, 2022., 2022
Objective. Autoimmune idiopathic inflammatory myopathies (IIMs) are a group of pathologies that are generally characterized by muscle weakness. Their treatment involves glucocorticoids and immunosuppressants. The aim was to identify differences and similarities in the pharmacological management of a group of patients with autoimmune IIMs according to ...
Luis Fernando Valladales-Restrepo, Ana Camila Delgado-Araujo, Brayan Stiven Aristizábal-Carmona, Lina María Saldarriaga-Rivera, Jorge Enrique Machado-Alba, Samar Tharwat   +5 more
wiley   +1 more source

Use of Drugs Associated with QT Interval Prolongation at the Hospital Level during the COVID‐19 Pandemic in Colombia

International Journal of Vascular Medicine, Volume 2022, Issue 1, 2022., 2022
Background. Many of the therapeutic proposals for COVID‐19 have been associated with adverse effects, including the risk of QT interval prolongation and torsades de pointes (TdP). The objective was to determine the use of drugs with a risk of QT interval prolongation in 21 clinics/hospitals in Colombia from January to December 2020. Methods. This cross‐
Andrés Gaviria-Mendoza, Manuel Enrique Machado-Duque, Luis Fernando Valladales-Restrepo, Carlos Fernando Tovar-Yepes, Jorge Enrique Machado-Alba, Baohui Xu   +5 more
wiley   +1 more source

Use of non‐vitamin K antagonist oral anticoagulants in Colombia: A descriptive study using a national administrative healthcare database

Pharmacoepidemiology and Drug Safety, Volume 30, Issue 4, Page 426-434, April 2021., 2021
Abstract Purpose We aimed to describe time‐trends in the use of NOACs among a group of ambulatory patients with nonvalvular atrial fibrillation (NVAF) in Colombia and to describe treatment patterns and user characteristics. Methods Using the Audifarma S.A administrative healthcare database in Colombia, we identified 10 528 patients with NVAF aged at ...
Jorge E. Machado‐Alba, Andrés Gaviria‐Mendoza, Manuel E. Machado‐Duque, Carlos Tovar‐Yepes, Ana Ruigómez, Luis Alberto García Rodríguez   +5 more
wiley   +1 more source

Hydrogen Peroxide as an Adjuvant Therapy for COVID‐19: A Case Series of Patients and Caregivers in the Mexico City Metropolitan Area

Evidence-Based Complementary and Alternative Medicine, Volume 2021, Issue 1, 2021., 2021
Knowledge of the antiseptic effects of hydrogen peroxide (H2O2) dates back to the late 19th century, and its mechanisms of action has been amply described. Globally, many physicians have reported using H2O2 successfully, in different modalities, against COVID‐19.
Arturo Cervantes Trejo, Isaac D. Castañeda, Alejandra Cortés Rodríguez, Victor R. Andrade Carmona, M. del Pilar Calva Mercado, Liliana Salgado Vale, Montserrat Cruz, Sara Barrero Castillero, Lucero Chavez Consuelo, Mauricio Di Silvio, Francisco Solano   +10 more
wiley   +1 more source

A vision for integrated publicly available information on regulated medical products

, 2022
Clinical and Translational Science, Volume 15, Issue 6, Page 1321-1327, June 2022.
Khyati Roberts, Roopal Thakkar, Lina Aljuburi, Donna Boyce, Sean Curtis, Jennifer Dudinak, Helen Fitton, Carlos Garner, Michael Garvin, Susan Longman, Edward Reilly, Jordan Maitland, Alexis Reisin Miller, Muriel Pasté, Michelle Rohrer, Mark Taisey, Karin Van Baelen, Max Wegner   +17 more
wiley   +1 more source

Farmacovigilância no Brasil: perfil das notificações de produtos a base de espécies vegetais base de espécies vegetais

Vigilância Sanitária em Debate, 2014
As plantas medicinais, utilizadas milenarmente pela humanidade, constituem um elo frágil dentro do contexto terapêutico, tanto pela regulamentação, ainda em construção, como pelo uso indiscriminado por sua taxação de inocuidade. Desse modo, seu monitoramento e acompanhamento pela farmacovigilância são essenciais para identificar, avaliar, compreender e
Luciane Otaviano de Lima, Milene Zanoni da silva Vosgerau, Eliane Carneiro Gomes   +2 more
openaire   +5 more sources

Farmacovigilância de drogas vegetais e seus derivados: uma ação necessária e já iniciada para a segurança do paciente, no contexto do uso racional de medicamentos

Vigilância Sanitária em Debate, 2015
Na antiguidade, o tratamento de enfermidades que acometiam os homens era essencialmente por meio de plantas medicinais. Com a revolução industrial no século XIX, essa alternativa de tratamento caiu em desuso. Nas últimas décadas, entretanto, voltou a ser empregada, devido a fatores como a dificuldade de acesso aos serviços médicos e farmacêuticos e o ...
Maria Aparecida Nicoletti, Rosilene Kinue Ito, André Rinaldi Fukushima, Aline Camata Leandro   +3 more
openaire   +5 more sources

2.7 Farmacovigilancia durante la pandemia de COVID-19

Anales del Sistema Sanitario de Navarra, 2023
Durante la pandemia de COVID-19, un papel fundamental de la Farmacovigilancia y del Centro de Farmacovigilancia de Navarra ha sido disponer de forma temprana de información de seguridad actualizada sobre los tratamientos para la infección por SARS-CoV-2
Gabriela Elizondo Rivas, Covadonga de Agapito Vicente, Ana Viñuales Loriente, Geno Ochando Ortiz   +3 more
doaj   +1 more source